Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Centene Corp (NYSE: CNC) Names Christopher Neczypor CFO Effective January 1, 2027

Centene Corp (NYSE: CNC) has named Christopher Neczypor as its new Chief Financial Officer, set to take on the role effective January 1, 2027. Neczypor will work closely with current CFO Drew Asher, who will step down in December 2026 and retire from the …

Vinay Lochav | 19 August 2026

Dermata Therapeutics Issues 933,064 Shares and Warrants in New Deal

Dermata Therapeutics, Inc. successfully raised approximately $3.2 million through a recent securities purchase agreement. The private placement involves the issuance of 933,064 shares of common stock priced at $1.46 each, providing the company with essentialCapitalto finance its planned corporate activities. Alongside these shares, Dermata …

Vinay Lochav | 19 August 2026

Iradimed Corp (NASDAQ: IRMD) Reports Q2 Revenue of $20.5M, Declares $0.20 Dividend

This slight improvement underscores the company's steady performance in the MRI-compatible medical devices market amid transitioning product lines. Despite the revenue gain,Net Incomedeclined 10% to $5.2 million from $5.8 million in the comparable quarter of 2025, highlighting that revenue growth was counterbalanced by pressure …

Vinay Lochav | 19 August 2026

Moderna (NASDAQ: MRNA) Shares Surge 142.5% to $152.67 on Cancer Vaccine Success

Moderna, Inc. (NASDAQ: MRNA), a biotechnology leader known for its mRNA technology, saw its stock surge 142.5% to $152.67 following favorable results from its cancer vaccine trials. This impressive rally is attributed to the experimental vaccine's success in preventing cancer recurrence, a landmark achievement …

Vinay Lochav | 19 August 2026

Accendra Health (NYSE: ACH) Halts Equity Issuance Plans, Plans $45M Asset Sales

Accendra Health Inc. (NYSE: ACH) has chosen to forego the establishment of an at-the-market equity issuance program given current market conditions. This program was envisioned to allow the company to raise modest amounts of equity to alleviate outstanding debt, particularly that trading below par …

Vinay Lochav | 19 August 2026

Coherus Oncology (NASDAQ: CHRS) Secures $55M Loan Facility With Lower Interest Rate

Coherus Oncology, Inc. (NASDAQ: CHRS) has successfully secured a senior secured term loan facility amounting to $55 million, with a maturity date set for August 2031. This strategic financial maneuver aims to provide greater flexibility and extends the company's debt obligations, ensuring that they …

Vinay Lochav | 19 August 2026

GE HealthCare (NASDAQ: GEHC) Appoints William Grogan as CFO, Effective September 14

GE HealthCare Technologies Inc. (NASDAQ: GEHC) is set to welcome William Grogan as its new Chief Financial Officer on September 14, 2026. Grogan succeeds George Newcomb, who has been serving in the interim capacity and will revert to his prior role as Controller and …

Vinay Lochav | 19 August 2026

Longevity Health Holdings Settles Litigation With Puritan Partners for $2.35M

Longevity Health Holdings, Inc. has announced a key settlement resolving its litigation with Puritan Partners LLC, which has been ongoing since November 2023. The settlement agreement entails exchanging existing claims for new 10% senior secured convertible notes valued at an aggregate principal amount of …

Vinay Lochav | 19 August 2026

Positron Corp (OTC: POSC) Secures $2M Line of Credit to Fund Growth

Positron Corp (OTC: POSC) has successfully established a line of credit that allows the company access to up to $2 million, a significant move intended to bolster its financial flexibility. This strategic financial maneuver is designed to support the company’s operational and growth initiatives.

Vinay Lochav | 19 August 2026

Auna Reports 9% Revenue Growth to $X, but Adjusted EBITDA Falls 9%

Revenue Growth Driven by Increased Patient Volumes

Vinay Lochav | 19 August 2026
Support

Hi! How can we help you today?

Loading…